Anti-Serpin-B13 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the amino-terminal region of mature human Serpin-B13, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Pan, Monkey
UniProt
Q9UIV8
Size
100ug
Cat. #
RP2SerpinB13

In stock

SKU
RP-SerpinB13

Options

As low as: $130.00

Target Overview

Serpin-B13 (UniProt Q9UIV8) is a 391-amino acid intracellular serine protease inhibitor belonging to the clade B serpin superfamily. Also known as headpin or hurpin, Serpin-B13 was originally identified as a UV-repressible serpin in HaCaT keratinocytes and is localized to the cytoplasm. Unlike classical inhibitory serpins that target extracellular proteases, clade B serpins lack a signal peptide and function intracellularly to regulate proteolytic pathways involved in cell differentiation, immune modulation, and inflammatory responses. Serpin-B13 is implicated in keratinocyte proliferation and differentiation, with expression patterns suggesting roles in epidermal homeostasis and barrier function. Recent studies have identified Serpin-B13 in transcriptomic signatures of inflammatory skin disorders including psoriasis and atopic dermatitis, and proteomic profiling has detected differential expression in epidermal nevus subtypes. Of particular interest, Kryvalap et al. (2021) reported that anti-Serpin-B13 autoantibodies correlate with pancreatic beta cell development and type 1 diabetes resistance, expanding the functional relevance of this serpin beyond the skin.

Background

Serpin-B13 belongs to the ov-serpin branch of clade B serpins, a group characterized by intracellular localization and regulatory roles distinct from the classical plasma protease inhibitors. The protein is expressed predominantly in stratified epithelia, with highest levels detected in skin, oral mucosa, and esophageal keratinocytes. Its function in keratinocyte biology is suggested by expression during differentiation and wound healing, though specific protease targets remain incompletely characterized. The serpin's alternative name, HaCaT UV-repressible serpin, reflects early observations that UV irradiation downregulates its expression in cultured keratinocytes, implicating Serpin-B13 in stress-response pathways relevant to photoaging and skin cancer. Transcriptomic studies have consistently identified SERPINB13 among genes differentially expressed in inflammatory dermatoses. Emmanuel et al. (2024) examined resolved psoriasis skin following secukinumab therapy versus Dead Sea climatotherapy, finding distinct molecular signatures that included serpin family members and suggesting persistent epigenetic changes in clinically healed lesions. Comparative transcriptome analyses of atopic dermatitis, psoriasis, and inflammatory acne have highlighted shared inflammatory gene networks in which SERPINB13 participates alongside well-characterized markers such as S100A9. Proteomic profiling of inflammatory linear verrucous epidermal nevus versus localized verrucous lesions revealed Serpin-B13 among proteins distinguishing inflammatory from non-inflammatory epidermal proliferation. The observation that naturally occurring anti-Serpin-B13 autoantibodies associate with preserved beta cell function and reduced type 1 diabetes risk represents an unexpected immunological dimension. This finding suggests that Serpin-B13 or its antibodies may modulate autoimmune responses beyond the epithelial compartment, although mechanisms remain under investigation. Researchers studying epithelial biology, inflammatory skin disease, protease regulation, and autoimmunity use Serpin-B13 reagents to map expression patterns, validate transcriptomic findings, and explore serpin-mediated cytoprotection.

References

  1. Kryvalap Y et al (2021) SerpinB13 antibodies promote β cell development and resistance to type 1 diabetes. Sci Transl Med. PubMed · 10.1126/scitranslmed.abf1587
  2. Yuan T et al (2022) Differences in clinical characteristics and lesion proteomics between inflammatory linear verrucous epidermal nevus and local verrucous epidermal nevus. J Proteomics. PubMed · 10.1016/j.jprot.2022.104554
  3. Emmanuel T et al (2024) Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory. Int J Mol Sci. PubMed · 10.3390/ijms25116086
  4. Wang W et al (2024) The Features of Shared Genes among Transcriptomes Probed in Atopic Dermatitis, Psoriasis, and Inflammatory Acne: S100A9 Selection as the Target Gene. Protein Pept Lett. PubMed · 10.2174/0109298665290166240426072642
  5. Wu S et al (2025) Machine learning-based prediction models for atopic dermatitis diagnosis and evaluation. Fundam Res. PubMed · 10.1016/j.fmre.2023.02.021

Additional Specifications

Gene Symbol SerpinB13
UniProt ID Q9UIV8
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Pan, Monkey
Pack Size 100ug
Immunogen (Amino end mature Serpin-B13)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-51.
Immunogen (Reactive Center Loop (RCL))Immunogen is proprietary and confidential. Immunogen generated in amino acid region 346-386.
Alternate Names SERPINB13, Serpin B13, HaCaT UV-repressible serpin, Hurpin, Headpin, Peptidase inhibitor 13, PI-13, Proteinase inhibitor 13, PI13

Frequently Asked Questions

What molecular weight band should I expect for Serpin-B13 on Western blot?

Serpin-B13 migrates at approximately 45-47 kDa on Western blot, which corresponds to the predicted molecular weight of the 391-amino acid protein. Because Serpin-B13 is an intracellular clade B serpin lacking a signal peptide, you should not observe higher molecular weight glycosylated forms. If you see multiple bands, consider post-translational modifications or proteolytic cleavage, though these are not widely reported for Serpin-B13. Use keratinocyte lysates such as HaCaT cells as a positive control, where Serpin-B13 is endogenously expressed.

What is the recommended starting dilution for Serpin-B13 antibody in Western blot?

Start at 1:1000 dilution in blocking buffer for Western blot, as validated with this antibody. Depending on expression levels in your sample and signal strength, you may need to optimize between 1:500 and 1:2000. Serpin-B13 expression is relatively low in most tissues, so keratinocyte or epidermal lysates will give stronger signal than fibroblasts or non-epithelial cells. Load 20-40 micrograms total protein per lane and use overnight incubation at 4°C if signal is weak at the recommended dilution.

Is Serpin-B13 expressed in normal human skin and which cell types should I use as positive controls?

Serpin-B13 is expressed in normal human epidermis, particularly in differentiating keratinocytes. HaCaT keratinocytes are the standard positive control, as this immortalized human keratinocyte line was used in the original identification of Serpin-B13 as a UV-repressible gene. Primary human keratinocytes and epidermal tissue lysates also express Serpin-B13. Expression is cytoplasmic and may be modulated by differentiation status, UV exposure, and inflammatory signals. Fibroblasts and non-epithelial cell lines typically show low or absent expression, making them suitable negative controls.

Does this Serpin-B13 antibody cross-react with mouse or rat samples?

This antibody is validated for human Serpin-B13 and cross-reactivity with monkey is predicted based on sequence homology. Cross-reactivity with mouse or rat has not been validated. Human and mouse Serpin-B13 share moderate sequence identity, so cross-reactivity is possible but should be confirmed experimentally in your hands. If working with rodent samples, include a species-specific positive control and consider peptide competition assays to confirm specificity. Pan-reactivity claims require empirical validation; we do not make unsupported cross-species guarantees.

Can I use this antibody for immunohistochemistry or immunofluorescence on skin sections?

This rabbit polyclonal is suitable for immunohistochemistry and immunofluorescence, methods routinely validated across our antibody line. For IHC on paraffin-embedded skin sections, use heat-mediated antigen retrieval with citrate buffer, pH 6.0. Start with 1:100 to 1:200 dilution and optimize based on background. Because Serpin-B13 is cytoplasmic, expect diffuse cytoplasmic staining in keratinocytes. For IF on cultured keratinocytes, fix with 4 percent paraformaldehyde, permeabilize with 0.1 percent Triton X-100, and begin at 1:50 to 1:100 dilution.

What sample preparation considerations are important for detecting Serpin-B13 in cell lysates?

Because Serpin-B13 is a cytoplasmic serine protease inhibitor, standard RIPA or NP-40 lysis buffers with protease inhibitor cocktail are appropriate. Avoid excessive boiling, which can aggregate serpins; heat samples at 95°C for 5 minutes maximum. Serpin-B13 expression may be low in non-keratinocyte samples, so use sufficient protein input (30-50 micrograms per lane). If studying UV or inflammatory regulation, harvest cells at defined time points post-treatment, as Serpin-B13 is UV-repressible and may fluctuate with differentiation state.

How should I store the Serpin-B13 antibody and what is the expected shelf life?

Store the antibody at -20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which degrade antibody activity over time. The 100-microgram pack size is sufficient for multiple experiments when aliquoted upon receipt. Once thawed, an aliquot can be stored at 4°C with 0.02 percent sodium azide for up to one month. Do not store diluted antibody in blocking buffer for more than one week. Properly stored aliquots remain stable for at least one year from receipt. Centrifuge briefly before use if precipitate forms after thawing.

Are there known isoforms or splice variants of Serpin-B13 I should be aware of?

Serpin-B13 is primarily expressed as a single 391-amino acid isoform encoded by the SERPINB13 gene on chromosome 18. Alternative splice variants have not been extensively characterized in the literature, and the UniProt entry Q9UIV8 lists the canonical sequence. This antibody is raised against a broad epitope region, so it should detect the full-length protein. If you observe multiple bands on Western blot, consider proteolytic cleavage or cross-reactivity rather than splice variants. The serpin family is large, so include peptide competition controls if specificity is critical.

Western blot validation for RP-SerpinB13 — 1 panel across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Serpin-B13: Amino end mature Serpin-B13 — WB validation
WB · Panel 1 Serpin-B13: Amino end mature Serpin-B13

Custom validation studies available on request — contact us.

Also known as:

  • SERPINB13
  • Serpin B13
  • HaCaT UV-repressible serpin
  • Hurpin
  • Headpin
  • Peptidase inhibitor 13
  • PI-13
  • Proteinase inhibitor 13
  • PI13
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →